Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (35)
Renato T. Stein & Heather J. Zar. (2023) RSV through the COVID‐19 pandemic: Burden, shifting epidemiology, and implications for the future. Pediatric Pulmonology 58:6, pages 1631-1639.
Crossref
Crossref
Aykut Eşki, Gökçen Kartal Öztürk, Candan Çiçek, Figen Gülen & Esen Demir. (2021) Is viral coinfection a risk factor for severe lower respiratory tract infection? A retrospective observational study. Pediatric Pulmonology 56:7, pages 2195-2203.
Crossref
Crossref
Robert M. Cox, Julien Sourimant, Mart Toots, Jeong-Joong Yoon, Satoshi Ikegame, Mugunthan Govindarajan, Ruth E. Watkinson, Patricia Thibault, Negar Makhsous, Michelle J. Lin, Jose R. Marengo, Zachary Sticher, Alexander A. Kolykhalov, Michael G. Natchus, Alexander L. Greninger, Benhur Lee & Richard K. Plemper. (2020) Orally efficacious broad-spectrum allosteric inhibitor of paramyxovirus polymerase. Nature Microbiology 5:10, pages 1232-1246.
Crossref
Crossref
Lyn Finelli, Yoonyoung Choi & Edward Goldstein. (2020) Number needed to immunize to prevent RSV with extended half-life monoclonal antibody. Vaccine 38:34, pages 5474-5479.
Crossref
Crossref
Nathaly Samy, Daniela Reichhardt, Darja Schmidt, Liddy M Chen, Günter Silbernagl, Sanja Vidojkovic, Thomas PH Meyer, Elke Jordan, Tatiana Adams, Heinz Weidenthaler, Daria Stroukova, Sonja De Carli & Paul Chaplin. (2020) Safety and immunogenicity of novel modified vaccinia Ankara-vectored RSV vaccine: A randomized phase I clinical trial. Vaccine 38:11, pages 2608-2619.
Crossref
Crossref
Muhammad Shafique, Muhammad Asif Zahoor, Muhammad Imran Arshad, Bilal Aslam, Abu Baker Siddique, Muhammad Hidayat Rasool, Muhammad Usman Qamar & Muhammad Usman. 2019. The Burden of Respiratory Syncytial Virus Infection in the Young. The Burden of Respiratory Syncytial Virus Infection in the Young.
Joyce U. Nyiro, Patience K. Kiyuka, Martin N. Mutunga, Charles J. Sande, Patrick K. Munywoki, J. Anthony G. Scott & D. James Nokes. (2019) Agreement between ELISA and plaque reduction neutralisation assay in Detection of respiratory syncytial virus specific antibodies in a birth Cohort from Kilifi, coastal Kenya.. Wellcome Open Research 4, pages 33.
Crossref
Crossref
Aleisha J. Anderson, Tom L. Snelling, Hannah C. Moore & Christopher C. Blyth. (2017) Advances in Vaccines to Prevent Viral Respiratory Illnesses in Children. Pediatric Drugs 19:6, pages 523-531.
Crossref
Crossref
Julian W Tang, Tommy T Lam, Hassan Zaraket, W Ian Lipkin, Steven J Drews, Todd F Hatchette, Jean-Michel Heraud, Marion P Koopmans, Ashta Mary Abraham, Amal Baraket, Seweryn Bialasiewicz, Miguela A Caniza, Paul KS Chan, Cheryl Cohen, André Corriveau, Benjamin J Cowling, Steven J Drews, Marcela Echavarria, Ron Fouchier, Pieter LA Fraaij, Todd F Hachette, Jean-Michel Heraud, Hamid Jalal, Lance Jennings, Alice Kabanda, Herve A Kadjo, Mohammed Rafiq Khanani, Evelyn SC Koay, Marion P Koopmans, Mel Krajden, Tommy T Lam, Hong Kai Lee, W. Ian Lipkin, Julius Lutwama, David Marchant, Hidekazu Nishimura, Pagbajabyn Nymadawa, Benjamin A Pinsky, Sanjiv Rughooputh, Joseph Rukelibuga, Taslimarif Saiyed, Anita Shet, Theo Sloots, JJ Muyembe Tamfum, Julian W Tang, Stefano Tempia, Sarah Tozer, Florette Treurnicht, Matti Waris, Aripuana Watanabe & Emile Okitolonda Wemakoy. (2017) Global epidemiology of non-influenza RNA respiratory viruses: data gaps and a growing need for surveillance. The Lancet Infectious Diseases 17:10, pages e320-e326.
Crossref
Crossref
Joyce U. Nyiro, Ivy K. Kombe, Charles J. Sande, James Kipkoech, Patience K. Kiyuka, Clayton O. Onyango, Patrick K. Munywoki, Timothy M. Kinyanjui & D. James Nokes. (2017) Defining the vaccination window for respiratory syncytial virus (RSV) using age-seroprevalence data for children in Kilifi, Kenya. PLOS ONE 12:5, pages e0177803.
Crossref
Crossref
Malgorzata Pawełczyk & Marek Leszek Kowalski. (2017) The Role of Human Parainfluenza Virus Infections in the Immunopathology of the Respiratory Tract. Current Allergy and Asthma Reports 17:3.
Crossref
Crossref
Gino Van Heeke, Koen Allosery, Veronique De Brabandere, Tim De Smedt, Laurent Detalle & Antonin de Fougerolles. (2017) Nanobodies® † †Nanobody is a registered trademark of Ablynx NV. as inhaled biotherapeutics for lung diseases. Pharmacology & Therapeutics 169, pages 47-56.
Crossref
Crossref
D. Jochmans, S. van Nieuwkoop, S. L. Smits, J. Neyts, R. A. M. Fouchier & B. G. van den Hoogen. (2016)
Antiviral Activity of Favipiravir (T-705) against a Broad Range of Paramyxoviruses
In Vitro
and against Human Metapneumovirus in Hamsters
. Antimicrobial Agents and Chemotherapy 60:8, pages 4620-4629.
Crossref
Crossref
Christopher Chiu & Peter J Openshaw. (2014) Antiviral B cell and T cell immunity in the lungs. Nature Immunology 16:1, pages 18-26.
Crossref
Crossref
Edward Anthony Goka, Pamela J. Vallely, Kenneth J. Mutton & Paul E. Klapper. (2014) Single and multiple respiratory virus infections and severity of respiratory disease: A systematic review. Paediatric Respiratory Reviews 15:4, pages 363-370.
Crossref
Crossref
Dingmei Zhang, Zhenjian He, Lin Xu, Xun Zhu, Jueheng Wu, Weitao Wen, Yun Zheng, Yu Deng, Jieling Chen, Yiwen Hu, Mengfeng Li & Kaiyuan Cao. (2014) Epidemiology characteristics of respiratory viruses found in children and adults with respiratory tract infections in southern China. International Journal of Infectious Diseases 25, pages 159-164.
Crossref
Crossref
Ashley Fowlkes, Andrea Giorgi, Dean Erdman, Jon Temte, Kate Goodin, Steve Di Lonardo, Yumei Sun, Karen Martin, Michelle Feist, Rachel Linz, Rachelle Boulton, Elizabeth Bancroft, Lisa McHugh, Jose Lojo, Kimberly Filbert, Lyn Finelli, Jennifer Lemmings, Brett Whitaker, Brian Lang, Ruth Lynfield, Larry Carroll, Dave Boxrud, Lillian Stark, Lea Heberlein-Larson, Valerie Mock, Lucy Desjardin, Mike Trythall, Jie Fu, Annette Atkinson, Lisa Gren, Erik Reisdorf, LaDonna Grenz, Christianne Biggs, Joan Sturgeon, Hector Rivas, Bruce Wolf, James Lute, Katie Kurkjian & Denise Toney. (2014) Viruses Associated With Acute Respiratory Infections and Influenza-like Illness Among Outpatients From the Influenza Incidence Surveillance Project, 2010–2011. The Journal of Infectious Diseases 209:11, pages 1715-1725.
Crossref
Crossref
Said H. Khayyata & Carol Farver. 2014. Viruses and the Lung. Viruses and the Lung
87
93
.
David Sperandio & Richard Mackman. 2013. Successful Strategies for the Discovery of Antiviral Drugs. Successful Strategies for the Discovery of Antiviral Drugs
29
62
.
Allison M. W. Malloy, Ann R. Falsey & Tracy J. Ruckwardt. 2013. Challenges and Opportunities for Respiratory Syncytial Virus Vaccines. Challenges and Opportunities for Respiratory Syncytial Virus Vaccines
211
231
.
Jeanne H. Schickli, Jasmine Kaur & Roderick S. Tang. (2012) Nonclinical phenotypic and genotypic analyses of a Phase 1 pediatric respiratory syncytial virus vaccine candidate MEDI-559 (rA2cp248/404/1030?SH) at permissive and non-permissive temperatures. Virus Research 169:1, pages 38-47.
Crossref
Crossref
M.J. Meijboom, M.H. Rozenbaum, A. Benedictus, W. Luytjes, M.C.J. Kneyber, J.C. Wilschut, E. Hak & M.J. Postma. (2012) Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The Netherlands. Vaccine 30:31, pages 4691-4700.
Crossref
Crossref
L. R. Bulkow, R. J. Singleton, C. DeByle, K. Miernyk, G. Redding, K. B. Hummel, L. Chikoyak & T. W. Hennessy. (2012) Risk Factors for Hospitalization With Lower Respiratory Tract Infections in Children in Rural Alaska. PEDIATRICS 129:5, pages e1220-e1227.
Crossref
Crossref
K. Kristensen, T. Hjuler, H. Ravn, E. A. F. Simoes & L. G. Stensballe. (2012) Chronic Diseases, Chromosomal Abnormalities, and Congenital Malformations as Risk Factors for Respiratory Syncytial Virus Hospitalization: A Population-Based Cohort Study. Clinical Infectious Diseases 54:6, pages 810-817.
Crossref
Crossref
Min-Shi Lee, Pai-Shan Chiang, Shu-Ting Luo, Mei-Liang Huang, Guan-Yuan Liou, Kuo-Chien Tsao & Tzou-Yien Lin. (2012) Incidence Rates of Enterovirus 71 Infections in Young Children during a Nationwide Epidemic in Taiwan, 2008–09. PLoS Neglected Tropical Diseases 6:2, pages e1476.
Crossref
Crossref
Mary K. McCarthy & Jason B. Weinberg. (2012) Eicosanoids and Respiratory Viral Infection: Coordinators of Inflammation and Potential Therapeutic Targets. Mediators of Inflammation 2012, pages 1-13.
Crossref
Crossref
Cristina Calvo, Maria Luz García-García, Patricia Ambrona, Miguel Rico, Francisco Pozo, M. Del Mar Molinero, Pilar Pérez-Breña & Inmaculada Casas. (2011) The Burden of Infections by Parainfluenza Virus in Hospitalized Children in Spain. Pediatric Infectious Disease Journal 30:9, pages 792-794.
Crossref
Crossref
David I. Bernstein, Judith Falloon & Tingting Yi. (2011) A randomized, double-blind, placebo-controlled, phase 1/2a study of the safety and immunogenicity of a live, attenuated human parainfluenza virus type 3 vaccine in healthy infants. Vaccine 29:40, pages 7042-7048.
Crossref
Crossref
Javier Díez & Victoria Planelles. (2011) Vacuna frente al virus respiratorio sincitial. Anales de Pediatría Continuada 9:1, pages 64-68.
Crossref
Crossref
Margarita Gomez, Maurice A. Mufson, Filip Dubovsky, Conor Knightly, Wen Zeng & Genevieve Losonsky. (2009) PHASE-I STUDY MEDI-534, OF A LIVE, ATTENUATED INTRANASAL VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS AND PARAINFLUENZA-3 VIRUS IN SEROPOSITIVE CHILDREN. Pediatric Infectious Disease Journal 28:7, pages 655-658.
Crossref
Crossref
Cyril Le Nou?n, Shirin Munir, St?phanie Losq, Christine C. Winter, Thomas McCarty, David A. Stephany, Kevin L. Holmes, Alexander Bukreyev, Ronald L. Rabin, Peter L. Collins & Ursula J. Buchholz. (2009) Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3. Virology 385:1, pages 169-182.
Crossref
Crossref
Kam-Lun Hon & Alexander K.C. Leung. (2009) Severe Childhood Respiratory Viral Infections. Advances in Pediatrics 56:1, pages 47-73.
Crossref
Crossref
Roderick S. Tang, Richard R. Spaete, Mark W. Thompson, Mia MacPhail, Jeanne M. Guzzetta, Patricia C. Ryan, Keith Reisinger, Patricia Chandler, Milo Hilty, Robert E. Walker, Margarita M. Gomez & Genevieve A. Losonsky. (2008) Development of a PIV-vectored RSV vaccine: Preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adults. Vaccine 26:50, pages 6373-6382.
Crossref
Crossref
Angelique G.S.C. Jansen, Elisabeth A.M. Sanders, Jacco Wallinga, Eelke J. Groen, Anton M. van Loon, Arno W. Hoes & Eelko Hak. (2008) Rate-difference method proved satisfactory in estimating the influenza burden in primary care visits. Journal of Clinical Epidemiology 61:8, pages 803-812.
Crossref
Crossref
Christine C. Robinson. (2007) The value of RVP in children's hospitals. Journal of Clinical Virology 40, pages S51-S52.
Crossref
Crossref